Mela Sciences (NSDQ:MELA) narrowed losses and met Wall Street’s expectations with its 4th-quarter results.
The Irvington, N.Y.-based melanoma detection device maker reported losses of $4.5 million, or 21¢ per share, in the 3 months ended Dec. 31, 2011. That compares with losses of $5.3 million, or 21¢ per share, during the same period in 2010.